- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
-
Friday, November 6th
Myriad's Not Doing Much
-
Wednesday, October 21st
Readers Ask: MHTX, SPNG.OB, NRIFF.PK
-
Tuesday, September 29th
Something's Rotten in the State of Sequenom (But Who Really Cares?)
-
Sunday, September 27th
Myriad Genetics: Horrendous Chart but Still Interesting
-
Monday, September 7th
Novavax's VLP Technology Is a Game Changer
-
Sunday, September 6th
Market Jitters Affect Allos
-
Thursday, August 27th
Myriad Genetics' Home Run Earnings Report
-
Tuesday, August 18th
Agilent: Rising Short Base, Low Utilization
-
Thursday, July 2nd
Healthcare: Branded Pharma Out, Diagnostics / Generics In
-
How Far Myriad Has Fallen: Is Information Leaking out?
-
Wednesday, June 24th
Monogram's Acquisition of LabCorp: What Does It Mean for the Molecular Diagnostics Industry?
-
Monday, June 8th
Antigenics: A Gift at $2
-
Wednesday, June 3rd
Antigenics: Rallying Cancer Vaccine Stock
-
Tuesday, June 2nd
Sequenom and the Small Cap Biotech Bipolar Experience
-
Thursday, May 14th
Gene Patenting Will Hinder Biotechs and Drugmakers from Curing Maladies
-
Tuesday, May 5th
Clarient: New Breast-Cancer Test
-
Tuesday, February 3rd
Two FDA New Product Decisions Expected This Week for Eli Lilly, Dyax
-
Wednesday, January 28th
EXACT Sciences Forms Pact with Genzyme
-
Wednesday, January 21st
Myriad Genetics - A Diagnostics Heavy Hitter
-
Create Your Own Diagnostics ETF
-
Wednesday, January 14th
Exact Sciences Plays Hard to Get with Sequenom
-
Tuesday, January 13th
In Search of Healthcare Diamonds in the Rough
-
A Closer Look at Sequenom's Offer for EXACT Sciences
-
Sunday, January 11th
20 Emerging Healthcare Stocks to Watch in '09